Skip to main content

Month: February 2023

Freshpet, Inc. to Report Fourth Quarter and Fiscal 2022 Results on Monday, February 27, 2023

SECAUCUS, N.J., Feb. 13, 2023 (GLOBE NEWSWIRE) — Freshpet, Inc. (NASDAQ: FRPT) (“Freshpet” or the “Company”) today announced it will report results for the fourth quarter and fiscal year ended December 31, 2022 on Monday, February 27, 2023 before market open. The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details. The conference call is scheduled to begin at 8:00 a.m. ET on Monday, February 27, 2023. To participate on the live call, listeners in North America may dial (877) 407-0792 and international listeners may dial (201) 689-8263. In addition, the call will be broadcast live over the Internet, hosted at the “Investor” section of the Company’s website at www.freshpet.com and will be archived online. A telephonic playback will be...

Continue reading

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2022 Financial Results

SAN DIEGO, Feb. 13, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company will host a conference call and live audio webcast on Tuesday, February 28, 2023 at 5:00 PM ET to report its fourth quarter and full year 2022 financial results and provide a corporate update. In order to participate in the conference call, please register using the conference link here. The live webcast can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast...

Continue reading

Enphase Energy and Lumio Expand Solar Technology Leadership Across the United States

FREMONT, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that Lumio, a leader in personalized renewable energy, will significantly expand its offering of Enphase® IQ8™ Microinverters and IQ™ Batteries to customers across the United States. Enphase® Energy Systems with IQ Batteries and the revolutionary IQ8 Microinverters, the industry’s first microgrid-forming microinverters launched late last year, offer homeowners even greater resilience than ever before. The strategic relationship with Lumio will amplify the impact and distribution of Enphase Energy Systems — providing homeowners more access to reliable, sustainable, and grid-independent power...

Continue reading

SmileDirectClub Introduces CarePlus Premium Aligner Offering

New service gives customers even more choice with expanded ways to get started and manage aligner care in-person or remotely NASHVILLE, Tenn., Feb. 13, 2023 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the oral care company with the first medtech platform for teeth straightening, today announced the launch of its new premium aligner treatment, CarePlus. Available now at select Partner Network dentist locations, CarePlus delivers a higher touch, tech-forward option in orthodontic care with greater flexibility and choice through a combination of both in-person and virtual patient management, value added services, and concierge-level care from SmileDirectClub’s network of licensed dentists, orthodontists, hygienists, and dental assistants. ​ To get started, CarePlus customers visit a participating Partner Network dental...

Continue reading

Akari Therapeutics Announces Acceleration of the Phase 3 Clinical Trial of Nomacopan for Treatment of Pediatric HSCT-TMA into Pivotal Part B and Addition of a New Pipeline Program Developing Nomacopan for HSCT-TMA in Adults

Based on Type C guidance requested and received from the U.S. Food and Drug Administration (FDA), Akari announces it is moving forward into design and planning for pivotal Part B of the Phase 3 clinical trial of nomacopan for treatment of pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) in pediatric patients between 2 years and

Continue reading

Saffron Oil Market is Predicted to Hit Revenue of USD 1.669 Billion by Growing with a CAGR of 7.6% During 2022-2028; Growing Usage of Saffron for the Medicinal and Cosmetic Purposes to Elevate Market Growth – SkyQuest

The most recent research study on the saffron oil market by SkyQuest offers crucial data on segments, sub-segments, and geographies to assist market participants and other stakeholders in determining the market’s pulse. Additionally, it provides great insights on product linage and product requirements among various territories that can help market players in product optimization, prioritizing their targeted regions, and designing effective supply chain solutions to cover a larger territory during a projection period. Westford, USA, Feb. 13, 2023 (GLOBE NEWSWIRE) — The North American region is anticipated to maintain its position as the market leader in the saffron oil market owing to consumers’ growing understanding of the value of a good diet and the dietary benefits of saffron maintaining a robust immune system....

Continue reading

Zeolite Market to Reach USD 5.71 Billion by 2029 | A Comprehensive Study of the Zeolite Industry Landscape

Key companies covered in zeolite market are Honeywell International Inc., Arkema S.A., Tosoh Corporation, BASF SE, W. R. Grace & Co., Clariant AG, Zeochem AG, Zeolyst International, Bear River Zeolite Co., Blue Pacific Minerals Ltd, St. Cloud Mining, Zeotech Corporation, Hengye Inc., Shijiazhuang Jianda High-tech Chemical Co., Ltd., KNT Group, International Zeolite Corp, and Others. Pune – India, Feb. 13, 2023 (GLOBE NEWSWIRE) — The global zeolite market size was USD 4.12 billion in 2021. The market is projected to grow from USD 4.28 billion in 2022 to USD 5.71 billion by 2029, exhibiting a CAGR of 4.2% during the forecast period. The zeolite market is a rapidly growing industry with a multitude of applications in various fields such as agriculture, construction, and industrial processes. With its unique chemical and...

Continue reading

Robotic Process Automation Market Size worth USD 50.50 Billion, Globally, by 2030 at a CAGR of 20.3%

The global robotic process automation market size is estimated to reach USD 50.50 billion by 2030. The market is expected to grow at 20.3% during this forecast period. Growing adoption across BFSI and healthcare sectors to aid adoption of robotic process automation: Fortune Business Insights™ Pune, India, Feb. 13, 2023 (GLOBE NEWSWIRE) — The robotic process automation market size was valued USD 10.01 billion in 2022. The global market for robotic process automation is projected to grow from USD 13.86 billion in 2023 to USD 50.50 billion in 2030, at Compound Annual Growth Rate (CAGR) of 20.3% during 2023 to 2030. RPA adoption is increasing across organizations of all sizes to generate greater Return on Investment (ROI) and boost productivity. Major market players are launching new Robotic Process Automation (RPA) solutions...

Continue reading

Foodservice Coffee Market to Reach Valuation of $554.02 Billion by 2029 | Foodservice Coffee Industry to Rise at CAGR 4.0%

Key Players Covered in the Foodservice Coffee Market are Starbucks Corporation (U.S.), The J.M Smucker Company (U.S.), Costa Limited (U.K.), The Coffee Bean & Tea Leaf (U.S.), Peet’s Coffee, Inc. (U.S.), Soho Coffee Co. (U.K.), The Kraft Heinz Company (U.S.), Ediya Co. Ltd. (South Korea), Juan Valdez (Colombia), Tim Hortons (Canada) and many more Pune, India, Feb. 13, 2023 (GLOBE NEWSWIRE) — The global foodservice coffee market size was valued at USD 406.68 billion in 2021 and USD 420.31 billion in 2022. The market is expected to reach USD 554.02 billion by 2029 with a CAGR of 4.0% during the forecast period. An increasing shift of consumers toward cold brew coffee is predicted to boost the demand for the product. Increasing coffee consumption in emerging economies and stronger interest in specialty coffee is set to...

Continue reading

Automation Instrumentation Market is Projected to Cross USD 89.32 Billion by 2028 at a CAGR of 5.8% from 2022–2028; Improving Product Quality with Reduction of Manufacturing Costs.

SkyQuest’s study on the automation instrumentation market is a crucial resource for anyone aiming to be ahead of the game. The report provides valuable information and insights that can benefit players in the industry, stakeholders, and investors. The study covers the latest market trends, leading players, and advancements, enabling readers to make informed decisions and stay ahead of the competition. So whether you are looking to invest, grow your business, or gain a deeper understanding of the market, this report is a must-read. Westford USA, Feb. 13, 2023 (GLOBE NEWSWIRE) — North America has a stronghold on the automation instrumentation market due to the high demand for advanced control and monitoring instrumentation for manufacturing purposes. In addition, industries are under growing pressure to increase their production...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.